Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1992 Aug;47(8):584–587. doi: 10.1136/thx.47.8.584

Corticosteroids in acute severe asthma: effectiveness of low doses.

S D Bowler 1, C A Mitchell 1, J G Armstrong 1
PMCID: PMC463917  PMID: 1412112

Abstract

BACKGROUND: Although the need for corticosteroids in acute severe asthma is well established the appropriate dose is not known. METHODS: The response to intravenous hydrocortisone 50 mg (low dose), 100 mg (medium dose), and 500 mg (high dose), administered every six hours for 48 hours and followed by oral prednisone, was compared in patients with acute asthma in a double blind randomised study. After initial emergency treatment with bronchodilators subjects received oral theophylline or intravenous aminophylline and nebulised salbutamol four hourly. Patients were given low, medium, or high doses of intravenous hydrocortisone and then 20, 40, or 60 mg/day respectively of oral prednisone with a reducing regimen over the following 12 days. Beclomethasone dipropionate, 400 micrograms twice daily by metered dose inhaler, was also started. Peak expiratory flow (PEF), forced expiratory volume in one second (FEV1), and visual analogue dyspnoea scores (VAS) were recorded daily in hospital and PEF and VAS twice daily after discharge for a total of 12 days. RESULTS: The 66 subjects (40 female) who completed the study had a mean (SD) age of 31(14) years. On presentation mean (SD) FEV1% predicted in the low (n = 22), medium (n = 20), and high dose (n = 24) groups was 17(13), 19(12), and 19(11) and after emergency bronchodilator treatment 32(20), 30(12), and 36(13). After 24 hours of treatment the respective post-bronchodilator FEV1% predicted values were 62(22), 62(23), and 65(28) compared with 71(24), 69(22), and 71(24) after 48 hours. No significant difference between the groups was detected. PEF and VAS improved with treatment over the 12 days but was not influenced by steroid dose. CONCLUSIONS: Hydrocortisone 50 mg intravenously four times a day for two days followed by low dose oral prednisone is as effective in resolving acute severe asthma as 200 or 500 mg of hydrocortisone followed by higher doses of prednisone.

Full text

PDF
584

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Britton M. G., Collins J. V., Brown D., Fairhurst N. P., Lambert R. G. High-dose corticosteroids in severe acute asthma. Br Med J. 1976 Jul 10;2(6027):73–74. doi: 10.1136/bmj.2.6027.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Collins J. V., Clark T. J., Brown D., Townsend J. The use of corticosteroids in the treatment of acute asthma. Q J Med. 1975 Apr;44(174):259–273. [PubMed] [Google Scholar]
  3. Dhand R., Kalra S., Malik S. K. Use of visual analogue scales for assessment of the severity of asthma. Respiration. 1988;54(4):255–262. doi: 10.1159/000195533. [DOI] [PubMed] [Google Scholar]
  4. Dwyer J., Lazarus L., Hickie J. B. A study of cortisol metabolism in patients with chronic asthma. Australas Ann Med. 1967 Nov;16(4):297–304. doi: 10.1111/imj.1967.16.4.297. [DOI] [PubMed] [Google Scholar]
  5. Fanta C. H., Rossing T. H., McFadden E. R., Jr Glucocorticoids in acute asthma. A critical controlled trial. Am J Med. 1983 May;74(5):845–851. doi: 10.1016/0002-9343(83)91076-8. [DOI] [PubMed] [Google Scholar]
  6. FitzGerald J. M., Hargreave F. E. The assessment and management of acute life-threatening asthma. Chest. 1989 Apr;95(4):888–894. doi: 10.1378/chest.95.4.888. [DOI] [PubMed] [Google Scholar]
  7. Harfi H., Hanissian A. S., Crawford L. V. Treatment of status asthmaticus in children with high doses and conventional doses of methylprednisolone. Pediatrics. 1978 Jun;61(6):829–831. [PubMed] [Google Scholar]
  8. Harrison B. D., Stokes T. C., Hart G. J., Vaughan D. A., Ali N. J., Robinson A. A. Need for intravenous hydrocortisone in addition to oral prednisolone in patients admitted to hospital with severe asthma without ventilatory failure. Lancet. 1986 Jan 25;1(8474):181–184. doi: 10.1016/s0140-6736(86)90654-9. [DOI] [PubMed] [Google Scholar]
  9. Haskell R. J., Wong B. M., Hansen J. E. A double-blind, randomized clinical trial of methylprednisolone in status asthmaticus. Arch Intern Med. 1983 Jul;143(7):1324–1327. [PubMed] [Google Scholar]
  10. Kraan J., Koëter G. H., van der Mark T. W., Boorsma M., Kukler J., Sluiter H. J., De Vries K. Dosage and time effects of inhaled budesonide on bronchial hyperreactivity. Am Rev Respir Dis. 1988 Jan;137(1):44–48. doi: 10.1164/ajrccm/137.1.44. [DOI] [PubMed] [Google Scholar]
  11. Raimondi A. C., Figueroa-Casas J. C., Roncoroni A. J. Comparison between high and moderate doses of hydrocortisone in the treatment of status asthmaticus. Chest. 1986 Jun;89(6):832–835. doi: 10.1378/chest.89.6.832. [DOI] [PubMed] [Google Scholar]
  12. Shee C. D. Risk factors for hydrocortisone myopathy in acute severe asthma. Respir Med. 1990 May;84(3):229–233. doi: 10.1016/s0954-6111(08)80040-6. [DOI] [PubMed] [Google Scholar]
  13. Smith M. J., Hodson M. E. High-dose beclomethasone inhaler in the treatment of asthma. Lancet. 1983 Feb 5;1(8319):265–269. doi: 10.1016/s0140-6736(83)91686-0. [DOI] [PubMed] [Google Scholar]
  14. Toogood J. H., Lefcoe N. M., Haines D. S., Jennings B., Errington N., Baksh L., Chuang L. A graded dose assessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthma. J Allergy Clin Immunol. 1977 Apr;59(4):298–308. doi: 10.1016/0091-6749(77)90051-3. [DOI] [PubMed] [Google Scholar]
  15. Webb J. R. Dose response of patients to oral corticosteroid treatment during exacerbations of asthma. Br Med J (Clin Res Ed) 1986 Apr 19;292(6527):1045–1047. doi: 10.1136/bmj.292.6527.1045. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES